The Indian market is expected to open flat on Monday tracking muted trend seen in other Asian markets.
Here is a list of top Ten stocks that are likely to be in focus today:
Jaiprakash Associates: The diversified Jaypee Group companies have defaulted on loans and other payments worth Rs 4,460 crore. The Group has on a consolidated basis failed to repay Rs 2,905.6 crore in principal amount to banks and another Rs 1,558.93 crore crore in interest payments.
Excel Crop Care Ltd: Japanese conglomerate Sumitomo Corp. has acquired 44.98% stake in Excel Crop Care Ltd BSE 0.73 % for around Rs.623.44 crore and also announced the launch of a Rs.415.80 crore open offer to acquire further 30% stake in the company.
Adani Enterprises: Indian conglomerate Adani Enterprise Ltd may walk away from its proposal to build one of the world’s biggest coal mines in Australia, citing long delays caused by legal challenges to the project by groups concerned about the environment.
Sun Pharma: A wholly owned US subsidiary of Indian drug maker Sun Pharma BSE 0.18 % has agreed to divest two oral solid dosage manufacturing facilities to Frontida BioPharma.
RIL: Less than three days of shut down, Reliance Industries has restarted its purified terephthalic acid (PTA) plants and is ramping up production to full capacity at Dahej. The PTA plants were shut on Tuesday due to increased water salinity.
HDFC: HDFC Ergo general insurance company, promoted by Housing Development Finance Corporation BSE 0.08 %, today agreed to buy L&T General Insurance for Rs 551 crore, first buyout in the general insurance industry.
Tata Motors: Jaguar Land Rover is suing Chinese automaker Jiangling Motor for allegedly copying the British firm’s Range Rover Evoque, said a media report.
Jubilant Life Sciences: Drug firm Jubilant Life Sciences BSE 4.67 % has received final approval from the US health regulator for generic Levetiracetam injection, used for treatment of epilepsy, in the American market.
Coal India: Mining behemoth Coal India BSE -0.99 % is likely to deliberate on a proposal to buy back its shares in its next board meeting. “Coal India had a meeting with the government last week and a buyback proposal is likely to be placed before the next board meeting,
Cipla: Three years since Cipla BSE 1.01 % New Ventures announced its plans to nurture innovative business ideas, the first product of that initiative has been approved under brand name Stempeucel, a drug that could possibly turn into a blockbuster.